| Hypotensive drugs and the cellular energetic potential. | |
| | |
MedLine Citation:
|
PMID: 1461173 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Clinical and experimental investigations have revealed changes of the Na, K, Ca and Mg concentration in serum and cells in patients with essential arterial hypertension (EAH). Some hypotensive drugs correct, more or less, the electrolytic abnormalities at the same time as the decrease of arterial pressure. Epidemiological studies have shown a lower arterial blood pressure in populations with decreased intake of Na and an increased intake of K, Ca and Mg. However the most frequently encountered electrolyte anomaly in patients with EAH is hypophosphatemia, mainly induced by a shift of inorganic phosphate from serum into the cells. Probably the increased influx of inorganic phosphate from the serum, increases the arterial cellular energetic potential. As hypotensive drugs lead to a reduction of the inorganic phosphate shift from serum into the cells one may suggest that the obtained decrease of arterial blood pressure may be at least partially due to a diminished energetic potential of certain cells. |
| | |
Authors:
|
G Uza |
Related Documents
:
|
20813373 - Extraction of essential oils from algerian myrtle leaves using instant controlled press... 2516863 - Is renal lithium clearance altered in essential hypertension? 2984913 - A parallel study of enalapril and captopril and 1 year of experience with enalapril tre... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Medical hypotheses Volume: 39 ISSN: 0306-9877 ISO Abbreviation: Med. Hypotheses Publication Date: 1992 Oct |
Date Detail:
|
Created Date: 1993-01-12 Completed Date: 1993-01-12 Revised Date: 2008-08-15 |
Medline Journal Info:
|
Nlm Unique ID: 7505668 Medline TA: Med Hypotheses Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 130-2 Citation Subset: IM |
Affiliation:
|
I Medical Clinic, Cluj-Napoca, Romania. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antihypertensive Agents
/
pharmacology* Clonidine / pharmacology Humans Hypertension / drug therapy, metabolism Nifedipine / pharmacology Phosphates / blood Propranolol / pharmacology Water-Electrolyte Balance / drug effects* |
| Chemical | |
Reg. No./Substance:
|
0/Antihypertensive Agents; 0/Phosphates; 21829-25-4/Nifedipine; 4205-90-7/Clonidine; 525-66-6/Propranolol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Sudden infant death syndrome (SIDS) and the immune response.
Next Document: Understanding the role of oxyradicals in general and in toxic hepatic damage can help safer drug des...